Wells Fargo
NVAX icon

Wells Fargo’s Novavax NVAX Stock Holding History

Wells Fargo’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,267,100
Closed -$7.98M – 7295
2025
Q2 		$7.98M Hold
1,267,100
– – ﹤0.01% 2104
2025
Q1 		$8.12M Buy
+1,267,100
New +$10.5M ﹤0.01% 2022
2022
Q3 		– Sell
-10,000
Closed -$514K – 7144
2022
Q2 		$514K Buy
+10,000
New +$518K ﹤0.01% 3728
2022
Q1 		– Sell
-1,800
Closed -$258K – 7583
2021
Q4 		$258K Buy
+1,800
New +$309K ﹤0.01% 5121
2021
Q3 		– Sell
-14,300
Closed -$3.04M – 7341
2021
Q2 		$3.04M Buy
+14,300
New +$2.62M ﹤0.01% 3321

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Wells Fargo's NVAX Position: Q2 2026 in Review

Wells Fargo increased its Novavax (NVAX) stake by 100% in Q2 2026, buying an estimated $609K and bringing the position to 135,826 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

Wells Fargo first reported a position in NVAX in Q3 2013 and has held it in 51 quarters since. The position peaked at $63.7M in Q2 2015. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Wells Fargo held 135,826 shares of Novavax worth $1.28M as of Q2 2026.
  • Wells Fargo bought 67,941 Novavax shares in Q2 2026, an estimated $609K.
  • Novavax made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3942 holding.
  • Wells Fargo first reported a position in Novavax in Q3 2013 and has held it in 51 quarters since.
  • Wells Fargo's Novavax position peaked at $63.7M in Q2 2015.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.